Borrelia burgdorferi is the causative agent of Lyme disease (4, 15) . The clinical manifestations of Lyme disease (16, 19) include erythema chronicum migrans and cardiac, neurologic, and articular symptoms. Because of the paucity of the organism in tissue and biologic fluids, isolation of B. burgdorferi is difficult (3) . At present, serodiagnosis is the only practical laboratory tool. The indirect fluorescent antibody test (6, 17) and its adaptations, namely the microimmunofluorescence test (micro-IF) (8) , the solid-phase fluoroimmunoassay (FIAX) (12) , and the enzyme-linked immunosorbent assay (13, 14) , are the main tests used for the detection of antibodies to B. burgdorferi. While the efficiencies of all these tests are relatively high during the later stages of Lyme disease, they are much lower during the early stage. Diagnosis remains essentially clinical in the early stage of the disease.
The specificity of these serological methods has been reported to be between 84 to 93% (6, 11, 14) . In this report, we have studied the cross-reaction of sera from patients with syphilis, leptospirosis, and acquired immunodeficiency syndrome with B. burgdorferi by using the micro-IF technique. In addition, we have confirmed a number of these micro-IF results by the immunoblot technique (5, 7, 13) .
MATERIALS AND METHODS
Sera. The following sera were used in this study. (i) We obtained 10 serum specimens from 10 patients from Marseille with Lyme disease, 3 of which specimens were sampled at an early stage (erythema chronicum migrans) and 7 Sera that scored reactive by the micro-IF were adsorbed with the Reiter treponema absorption reagent used in the fluorescent treponemal antibody absorption test for syphilis (Behringwerke AG, Marburg, Federal Republic of Germany) as described in the kit instructions. The sera were then retested by micro-IF. Briefly, the sera were diluted (1:16) in absorption medium (ultrasonicate of Reiter spirochetes) and the mixture was incubated for 60 min in a water bath at 37°C. For titration, the sera were further diluted in the absorption medium.
Antigen preparations. B. burgdorferi was grown in Barbour-Stoenner-Kelly (BSK II) medium (2) for 4 to 7 days, centrifuged, washed with phosphate-buffered saline (PBS), and then pelleted and adjusted to a protein concentration of 2 mg of protein per ml in distilled water by using a commercially available assay (Bio-Rad Laboratories, Richmond, Calif.).
Micro-IF. The organism was first mixed with 6% (vol/vol) egg yolk suspension in PBS (pH 7.2) and applied by dip-pen point (artist's pen) to microscope slides, air dried, and fixed for 20 min in cold acetone. The sera were diluted 1:25 in PBS containing 3% nonfat dry milk. The sera were incubated at 37°C for 30 min in a moist chamber, washed three times in PBS, and then incubated with fluorescein-conjugated goat anti-total human immunoglobulin (Bio-Merieux, Lyon, with a Nikon epifluorescence microscope at x400. The reactive sera were further tested by using fluorescein-conjugated goat anti-human immunoglobulin M (IgM) (,u chain specific) and IgG (-y chain specific) to determine anti-B. burgdorferi IgM and IgG, respectively.
Electrophoresis and immunoblotting. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed (10, 18) . The B. burgdorferi was solubilized in a solution containing 2% sodium dodecyl sulfate and 5% 2-mercaptoethanol. The samples were applied to a 3.9% stacking gel, and the antigens were electrophoresed on a 10% separating gel at a constant current of 20 mA at 20°C. The proteins were transferred to nitrocellulose sheets (18) for 4 h with a current of 500 mA at +4°C. After transfer, the sheet was blocked in Tris-buffered saline, pH 8.0 (TBS), containing 5% nonfat dry milk overnight. The sheet was then washed with TBS, dried, cut into 0.5-cm lanes, and stored at 5°C until further use. Each serum specimen was diluted to 1:100 with TBS containing 3% non fat dry milk and incubated with a lane containing the electrophoresed and electroblotted antigens overnight at 20°C with rocking. Each lane was then washed three times for 10 min in TBS and incubated for 2 h in peroxidase-conjugated goat anti-human immunoglobulin diluted 1:400 in TBS-3% milk. The lane was washed three times in TBS, and the antigen-antibody reaction was revealed with horseradish peroxidase-color development reagent containing 4-chloro-1-naphthol (Bio-Rad).
RESULTS
Eight serum specimens from Lyme disease patients were micro-IF positive before and after absorptions. Three of these serum specimens had both IgG and IgM to B. burgdorferi. The eight positive cases reacted in the immunoblot (>5 bands). The immunoblot test result for Lyme disease patient 5 is shown in Fig. 1 . Among the 100 serum specimens reactive in tests for syphilis, 37 were micro-IF positive before absorption and 4 were micro-IF positive after absorption. The antibodies in these sera were of the IgG class. The immunoblot test results for syphilis patients 6, 7, and 8 are shown in Fig. 1 . Antibodies in these sera were mostly against an antigen band with an approximate molecular mass of 38 kilodaltons.
Among the 100 serum specimens from patients with leptospirosis, 23 were weakly micro-IF positive (IgG, <200; IgM, <50) and 7 were positive before and after absorption. Of the latter specimens, six were from L. icterohaemorrhagiae infections and one was from an L. grippotyphosa infection; six had IgM (ranging from 1:50 to 1:800), and six had IgG (from 1:100 to 1:800). The immunoblot test results for four of these seven patients are shown in Fig. 2 . Two serum specimens reacted with .5 antigen bands, and five serum specimens reacted with .2 bands. In the two former cases (Fig. 2, patients 1 and 2 
DISCUSSION
The specificity of the IFA for Lyme disease has been reported to be 84 to 93%, depending on the inclusion of treponemal infections (6, 9, 14) . To our knowledge, HIVpositive sera were not tested previously, and leptospirosis sera were tested in small numbers (14) . In 1986, the Marseille Laboratory received 5,000 serum specimens for HIV testing; 1,796 were positive for HIV. Seventy-nine percent of the patients were drug addicts. If we project our results from all the serum specimens which were positive for HIV (1, 794) in the Marseille region, 54 (3%) of the serum specimens after absorption would be micro-IF reactive for Lyme disease. This cross-reaction is not related to syphilis, because we selected sera nonreactive in tests for syphilis.
At the Marseille Laboratory, we test per year approximately 20,000 serum specimens for syphilis and we have found that approximately 5,000 serum specimens score positive for syphilis. We have randomly tested 100 sera reactive in tests for syphilis and found that 4% were still positive in the micro-IF for Lyme disease after absorption. Hunter et al. (9) reported that the cross-reaction observed with syphilis sera was absorbed by using Reiter treponema. In our study, using a commercial Reiter treponemal preparation, four serum specimens remained positive. This may be related to the procedure of absorption, which was different in our study. These results imply that 200 serum specimens positive for syphilis would also be positive for Lyme disease. Thus, the serodiagnosis of these sera would be based on the RPR card test (14) , which detects antibody to cardiolipin produced during the course of syphilitic infection but not 
